Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States
Anita Afzali, Kristin Berry, George N. Ioannou – 19 September 2011 – Because of the ongoing epidemics of obesity and diabetes, nonalcoholic steatohepatitis (NASH) may become a leading indication for liver transplantation. There are concerns about the posttransplant survival of patients with NASH because of associated cardiovascular and metabolic risk factors. We aimed to determine recent trends in the proportion of patients undergoing transplantation for NASH‐related cirrhosis in the United States and to estimate their posttransplant survival.